News & Updates

Treatment with fezolinetant 45 mg outperforms other nonhormone therapies (non-HTs) in terms of minimizing the frequency of moderate-to-severe vasomotor symptoms (VMS) in women undergoing menopause, according to a study from the US.

Maternal cannabis use during pregnancy appears to contribute to increased risk of adverse neonatal health outcomes, including low birth weight (LBW) and small for gestational age (SGA), as reported in a study.

Women with a history of pre-eclampsia are at increased risk of venous thromboembolism during pregnancy, according to a study.

For expectant mothers with acute cholecystitis (AC), undergoing cholecystectomy lowers the risk of adverse pregnancy outcomes, according to a large study.

Initiation of vaginal micronized progesterone during the first trimester appears to reduce the risk of hypertensive disorders of pregnancy (HDP) and pre-eclampsia, according to a study.

An 8-week course is as good as a 12-week course of tenofovir alafenamide fumarate (TAF) therapy in terms of preventing the transmission of hepatitis B virus (HBV) infection from mothers to infants, as reported in a study.